Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on developing IL-1-based treatments for immune-mediated inflammatory diseases. The company's lead product candidate, abdakibart (AVTX-009), is in a Phase 2 clinical trial for hidradenitis suppurativa.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.